Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines

Paola Massi, Angelo Vaccani, Stefania Ceruti, +3

Journal of Pharmacology and Experimental Therapeutics

The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells

Paola Massi, Angelo Vaccani, Silvia Bianchessi, +3

Cellular and Molecular Life Sciences

Neuro-oncologyHuman Glioma CellsMedicineCell DeathNon-psychoactive Cannabidiol Triggers +6

CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour

Tiziana Rubino, C. Guidali, Daniela Viganò, +4

Neuropharmacology

NeuropsychologyAnxiety-related BehaviourAffective NeurosciencePsychopharmacologySocial Sciences +14

Cannabidiol inhibits angiogenesis by multiple mechanisms

Marcello Solinas, Paola Massi, R. Cammarota, +6

British Journal of Pharmacology

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor‐independent mechanism

Angelo Vaccani, Paola Massi, A Colombo, +2

British Journal of Pharmacology

Pertussis ToxinGliomaCannabinoid PharmacologyTumor BiologyCannabinoid Receptor‐independent Mechanism +15

Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect

Marta Solinas, Paola Massi, Valentina Cinquina, +6

PLoS ONE

Chemoprevention StrategyMultitarget EffectGliomaCannabinoid PharmacologyCbd Treatment +18

5‐Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non‐psychoactive cannabinoid

Paola Massi, Marta Valenti, Angelo Vaccani, +6

Journal of Neurochemistry

Antitumor ActivityGliomaCannabinoid PharmacologyTumor BiologyNeuro-oncology +16

The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro

Paola Sacerdote, Cataldo Martucci, Angelo Vaccani, +5

Journal of Neuroimmunology

InflammationCannabis UseMedicineImmunologyCannabis Legalization +7

In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors

Paola Sacerdote, Paola Massi, Alberto E. Panerai, +1

Journal of Neuroimmunology

InflammationCannabis UseSynthetic Cannabinoid Cp55,940Cb2 ReceptorsFunctional Selectivity +7

Changes in the Cannabinoid Receptor Binding, G Protein Coupling, and Cyclic AMP Cascade in the CNS of Rats Tolerant to and Dependent on the Synthetic Cannabinoid Compound CP55,940

Tiziana Rubino, Daniela Viganò, Paola Massi, +1

Journal of Neurochemistry